Alvotech (ALVO)
12.44
+0.02
(+0.16%)
USD |
NASDAQ |
Nov 21, 16:00
12.40
-0.04
(-0.32%)
After-Hours: 20:00
Alvotech Net Income (Quarterly): -11.39M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -11.39M |
| June 30, 2024 | 65.22M |
| March 31, 2024 | -218.73M |
| December 31, 2023 | -276.56M |
| September 30, 2023 | -188.32M |
| June 30, 2023 | 189.33M |
| March 31, 2023 | -276.18M |
| Date | Value |
|---|---|
| December 31, 2022 | -320.51M |
| September 30, 2022 | -8.602M |
| June 30, 2022 | -107.49M |
| March 31, 2022 | -76.98M |
| December 31, 2021 | 253.76M |
| September 30, 2021 | -81.32M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-320.51M
Minimum
Dec 2022
253.76M
Maximum
Dec 2021
-81.37M
Average
-81.32M
Median
Sep 2021
Net Income (Quarterly) Benchmarks
| Procaps Group SA | 8.194M |
| Johnson & Johnson | 2.694B |
| Pfizer Inc | 4.465B |
| Rigel Pharmaceuticals Inc | 12.42M |
| NovaBay Pharmaceuticals Inc | -1.212M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 102.89M |
| Total Expenses (Quarterly) | 90.16M |
| EPS Diluted (Quarterly) | -0.02 |
| Enterprise Value | 4.654B |
| Gross Profit Margin (Quarterly) | 61.31% |
| Profit Margin (Quarterly) | -11.07% |
| Earnings Yield | -14.92% |
| Normalized Earnings Yield | -8.846 |